Henning Rattunde

Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial

Anthony Barnett, Ambrish Mithal, Jenny Manassie et al. · The Lancet Diabetes & Endocrinology · 2014 · 567 citations

Diabetes Management, Insulin Management, Diabetes +8

Direct Renin Inhibition in Addition to or as an Alternative to Angiotensin Converting Enzyme Inhibition in Patients with Chronic Systolic Heart Failure: Rationale and Design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) Study

Henry Krum, Barry M. Massie, William T. Abraham et al. · European Journal of Heart Failure · 2010 · 127 citations · Full text

Empagliflozin Monotherapy in Japanese Patients with Type 2 Diabetes Mellitus: a Randomized, 12-Week, Double-Blind, Placebo-Controlled, Phase II Trial

Takashi Kadowaki, Masakazu Haneda, Nobuya Inagaki et al. · Advances in Therapy · 2014 · 85 citations

Diabetes Management, Cardiovascular Disease, Diabetes +7

Rationale and Design of the Multicentre, Randomized, Double-Blind, Placebo-Controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT)

Mihai Gheorghiade, Mazen Albaghdadi, Faı̈ez Zannad et al. · European Journal of Heart Failure · 2010 · 79 citations · Full text

Acute Lower Gastrointestinal Hemorrhage: Minimally Invasive Management with Microcatheter Embolization

Ralph Kickuth, Henning Rattunde, Jürgen Gschossmann et al. · Journal of Vascular and Interventional Radiology · 2008 · 77 citations

Pulmonary Embolism, Microcatheter Embolization, Vascular Surgery +5